Integer Holdings (ITGR) Cash from Operations Growth (1y) (2011 - 2026)
Integer Holdings (ITGR) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.40 Bn | 176.11 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 68.71 Bn | 67.25 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn | -84.38% |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn | 185.96% |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | 16.00% |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 122.43% |
| 10 | Integer Holdings | 3.40 Bn | 3.39 Bn | 109.60 Mn | -21.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -21.04% |
| Dec 31, 2025 | -12.36% |
| Sep 26, 2025 | -8.26% |
| Jun 27, 2025 | -7.14% |
| Mar 28, 2025 | 34.58% |
| Dec 31, 2024 | 13.75% |
| Sep 27, 2024 | 14.78% |
| Jun 28, 2024 | -15.87% |
| Mar 29, 2024 | 275.55% |
| Dec 31, 2023 | 7.72% |
| Sep 29, 2023 | 124.33% |
| Jun 30, 2023 | 197.85% |
| Mar 31, 2023 | -65.93% |
| Dec 31, 2022 | 31.45% |
| Sep 30, 2022 | -42.89% |
| Jul 1, 2022 | -41.75% |
| Apr 1, 2022 | -50.15% |
| Dec 31, 2021 | -44.79% |
| Oct 1, 2021 | 50.61% |
| Jul 2, 2021 | -28.97% |